Why peptides arrive as a powder

First, what does "lyophilized" mean?

If you open a box of research peptides, you will most likely find glass vials holding what looks like almost nothing: a small pellet or a layer of white powder at the bottom. It is not a mistake or an empty vial. It is the most common way to supply a peptide, and there is a good reason for it.

That powder is called a lyophilizate. The word comes from lyophilization, which in plain language is freeze-drying: removing the water from a solution without heating it. The European guideline on synthetic peptides (molecules built in the laboratory, one amino acid at a time) describes lyophilization as common practice for isolating the final peptide⁵. The FDA inspection guide explains why: many products are made in lyophilized form because they are unstable in solution, and it lists the enhanced stability of a dry powder among the method's advantages⁶.

You already know freeze-dried products. Good instant coffee is made this way, and so are crunchy dried fruits and astronaut food: NASA notes that freeze-dried powders were already flown on the Mercury missions⁷. The water is taken out, the product keeps for a long time and, when it is needed, liquid is added back.

How freeze-drying works

The process has three stages, each with its own logic².

• Freezing. The peptide solution is frozen inside the vial. The water forms ice crystals and the peptide is trapped between them². This stage already asks a lot of the molecule: low temperature, ice formation and the concentration of whatever stays dissolved are the three main stresses specialists study¹⁴.
• Primary drying. The pressure is lowered a great deal, as if almost all the air were pumped out of the chamber. Under those conditions, ice turns straight into vapor without becoming liquid; this jump is called sublimation⁶. It is the same thing that happens when dry ice "smokes".
• Secondary drying. The temperature is raised a little to remove the moisture still clinging to the molecule².

What remains is a dry, porous structure in the shape the liquid had inside the vial. Designing these stages well is a science of its own: there are whole reviews devoted to choosing temperatures and pressures so that the product comes out stable and well formed².

Often the solution contains, besides the peptide, an excipient: a companion ingredient that is not the active substance. Some excipients protect the molecule during freezing and drying, and others, called bulking agents, give the powder body so that it forms properly¹¹². A widely used one is mannitol, a sugar alcohol whose behavior during freezing and drying has been studied in detail¹³.

Why the powder lasts longer than the liquid

A peptide is a chain of amino acids, and water is the stage on which almost all the chemical reactions that slowly wear it down take place. When water is present, molecules move, collide and react. When the water is removed, all of that slows down dramatically. The best-known reactions have their own names, such as deamidation, oxidation and breaks in the chain⁸⁹.

That is why the pharmaceutical industry turns many proteins and peptides into solids: it gives them an acceptable shelf life, something that would be hard to achieve in solution¹¹⁰. Note that the solid state does not stop everything, it only slows it down; some of those reactions can still happen in a powder⁸¹⁰. It is the same idea as taking powdered milk on a long trip instead of fresh milk.

Powder stability does have its allies and its enemies. In a classic study of a freeze-dried model peptide, residual moisture (the water left in the powder), temperature and the type of bulking agent all influenced how much it degraded over time⁴. Something similar was seen with a freeze-dried antibody: powders holding more moisture lost chemical stability faster¹¹. Peptides are also often very hygroscopic powders, meaning they attract moisture from the air the way salt does on a rainy day⁵. That is why the vial arrives tightly sealed: it keeps the powder dry.

The "cake": what normal looks like

In the laboratory, the block of powder at the bottom is called the cake. Ideally, specialists say, it is a uniform, good-looking cake, and that remains an important goal when a freeze-dried product is designed³. The FDA itself counts cake appearance among the points reviewed in a freeze-dried product⁶.

In practice, a normal cake usually looks like this:

• Color: white or off-white.
• Shape: a compact pellet at the bottom, or loose powder if the vial was jostled during shipping.
• Size: it can look very small, because a few milligrams of peptide take up very little space, especially when there is no bulking agent.

The reassuring part is that a cake that does not look perfect does not always signal a problem. A commentary by experts from industry and academia puts it this way: "‘sometimes’ a non-ideal cake appearance has no impact on product quality and is an inherent characteristic of the product"³. The same paper proposes a shared vocabulary for describing those variations, so that laboratories speak the same language³.

What this means for your laboratory

For a physician, clinic or laboratory that is just starting out, the key idea is simple: the powder is not a "half-finished" peptide; it is the peptide in its most stable form, ready to travel and to wait. The work begins when the researcher decides to turn it back into a solution.

Understanding the lyophilizate also helps you read the information that comes with the vial. Figures such as water content appear on certificates of analysis precisely because peptide powders attract moisture⁵; the FDA calls the amount of moisture in the vials an obvious concern for any freeze-dried product⁶. We will look at that calmly later in this series.